GIM
BLUE

Granahan Investment Management’s bluebird bio BLUE Stock Holding History

Granahan Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-385,583
Closed -$9.87M – 181
2024
Q1 		$9.87M Sell
385,583
-18,302
-5% -$469K 0.35% 86
2023
Q4 		$11.1M Buy
403,885
+146,996
+57% +$8.96M 0.37% 84
2023
Q3 		$15.6M Buy
256,889
+14,073
+6% +$989K 0.56% 53
2023
Q2 		$16M Buy
242,816
+170,553
+236% +$12.5M 0.49% 61
2023
Q1 		$4.6M Buy
72,263
+36,787
+104% +$4.2M 0.14% 131
2022
Q4 		$4.91M Buy
35,476
+6,022
+20% +$848K 0.15% 132
2022
Q3 		$3.73M Buy
+29,454
New +$3.33M 0.12% 142
2021
Q1 		– Sell
-4,639
Closed -$2.6M – 194
2020
Q4 		$2.6M Sell
4,639
-2,681
-37% -$1.7M 0.06% 166
2020
Q3 		$5.12M Sell
7,320
-861
-11% -$671K 0.17% 105
2020
Q2 		$6.47M Buy
+8,181
New +$6.17M 0.23% 96

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Granahan Investment Management's BLUE Position: Q2 2024 in Review

Granahan Investment Management sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 385,583 shares — an estimated $9.87M sold.

Granahan Investment Management first reported a position in BLUE in Q2 2020 and held it in 10 quarters. The position peaked at $16M in Q2 2023. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.

  • Granahan Investment Management reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
  • Granahan Investment Management sold 385,583 bluebird bio shares in Q2 2024, an estimated $9.87M.
  • Granahan Investment Management first reported a position in bluebird bio in Q2 2020 and held it in 10 quarters.
  • Granahan Investment Management's bluebird bio position peaked at $16M in Q2 2023.
  • 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.

Based on Granahan Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.